Abstract
Using computer-assisted combinatorial chemistry techniques, we have designed a virtual library of antiinfluenza agents, analogs of inhibitor A-315675, containing a novel pyrrolidine core, which effectively inhibits both wild type and common oseltamivir-resistant mutant forms of the neuraminidase (NA) subtype N1 of avian influenza virus H5N1. A target-specific Potential of Mean Force (PMF) scoring function parameterized on a training set of 13 known pyrrolidine-based inhibitors of NA and validated on 3 others was used to predict the N1 inhibition constants for the focused library of A-315675 analogs. Nine virtual hits (best pyrrolidine inhibitors designed in the present study) are predicted to exhibit inhibition constants in the low picomolar range, up to 200 fold lower than the parent inhibitor A- 315675 while displaying favorable predicted ADME-related properties. Proposed small highly-focused combinatorial subsets composed of R-groups most frequently occurring in the 200 most active analogs can be useful as a guide for synthetic and medicinal chemists who are developing a new generation of drugs against the avian influenza virus H5N1 by focusing their attention on this small portion of the chemical space.
Keywords: Avian influenza virus H5N1, neuraminidase inhibitors, viral drug resistance, pyrrolidine-based analogs, computerassisted combinatorial library design, in silico screening, target-specific scoring function
Combinatorial Chemistry & High Throughput Screening
Title: Combinatorial Design of Avian Influenza Neuraminidase Inhibitors Containing Pyrrolidine Core with a Reduced Susceptibility to Viral Drug Resistance
Volume: 13 Issue: 3
Author(s): Thanyada Rungrotmongkol, Thanyarat Udommaneethanakit, Vladimir Frecer and Stanislav Miertus
Affiliation:
Keywords: Avian influenza virus H5N1, neuraminidase inhibitors, viral drug resistance, pyrrolidine-based analogs, computerassisted combinatorial library design, in silico screening, target-specific scoring function
Abstract: Using computer-assisted combinatorial chemistry techniques, we have designed a virtual library of antiinfluenza agents, analogs of inhibitor A-315675, containing a novel pyrrolidine core, which effectively inhibits both wild type and common oseltamivir-resistant mutant forms of the neuraminidase (NA) subtype N1 of avian influenza virus H5N1. A target-specific Potential of Mean Force (PMF) scoring function parameterized on a training set of 13 known pyrrolidine-based inhibitors of NA and validated on 3 others was used to predict the N1 inhibition constants for the focused library of A-315675 analogs. Nine virtual hits (best pyrrolidine inhibitors designed in the present study) are predicted to exhibit inhibition constants in the low picomolar range, up to 200 fold lower than the parent inhibitor A- 315675 while displaying favorable predicted ADME-related properties. Proposed small highly-focused combinatorial subsets composed of R-groups most frequently occurring in the 200 most active analogs can be useful as a guide for synthetic and medicinal chemists who are developing a new generation of drugs against the avian influenza virus H5N1 by focusing their attention on this small portion of the chemical space.
Export Options
About this article
Cite this article as:
Rungrotmongkol Thanyada, Udommaneethanakit Thanyarat, Frecer Vladimir and Miertus Stanislav, Combinatorial Design of Avian Influenza Neuraminidase Inhibitors Containing Pyrrolidine Core with a Reduced Susceptibility to Viral Drug Resistance, Combinatorial Chemistry & High Throughput Screening 2010; 13 (3) . https://dx.doi.org/10.2174/138620710790980504
| DOI https://dx.doi.org/10.2174/138620710790980504 |
Print ISSN 1386-2073 |
| Publisher Name Bentham Science Publisher |
Online ISSN 1875-5402 |
Call for Papers in Thematic Issues
Multi-Omics and Multimodal Data Fusion in Drug Discovery: From Target Identification to Personalized Therapy
Modern drug discovery faces systemic challenges in combating complex diseases, whose mechanisms involve interactive networks across genomic, transcriptomic, proteomic, metabolomic, and other molecular layers. Single-omics or conventional approaches often fail to capture this complexity comprehensively. This thematic issue explores strategies for integrating multi-omics data (including genomics, transcriptomics, proteomics, metabolomics, and ...read more
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Phytochemical and Pharmacological Overview of Triticum aestivum: An
Update
Current Traditional Medicine Non-alcoholic Fatty Liver Disease in Children
Current Vascular Pharmacology Regulation of Apoptosis by Gram-Positive Bacteria: Mechanistic Diversity and Consequences for Immunity
Current Immunology Reviews (Discontinued) The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors
Current Cancer Therapy Reviews Impacts of Dietary Protein from Fermented Cottonseed Meal on Lipid Metabolism and Metabolomic Profiling in the Serum of Broilers
Current Protein & Peptide Science Synthesis, Antimicrobial and Antioxidant Activities of Some Benzimidazole Derivatives
Letters in Drug Design & Discovery Breath Analysis: The Approach Towards Clinical Applications
Mini-Reviews in Medicinal Chemistry Post-translational and Post-transcriptional Modifications of Pregnane X Receptor (PXR) in Regulation of the Cytochrome P450 Superfamily
Current Drug Metabolism Abelson Tyrosine-Protein Kinase 1 as Principal Target for Drug Discovery Against Leukemias. Role of the Current Computer-Aided Drug Design Methodologies
Current Topics in Medicinal Chemistry NF-κB Signaling Pathway Inhibitors as Anticancer Drug Candidates
Anti-Cancer Agents in Medicinal Chemistry Anti-Inflammatory Approaches to Reduce Acute Cardiovascular Events: Not Only Benefits
Current Pharmaceutical Biotechnology Volsurf Descriptors to Analyse Anti-HCV and Cytotoxic Activities of Sesquiterpene Lactones from Asteraceae Family
Letters in Drug Design & Discovery Drug Design For Flavivirus Proteases: What Are We Missing?
Current Pharmaceutical Design Antisense Technologies Targeting Fatty Acid Synthetic Enzymes
Recent Patents on Anti-Cancer Drug Discovery Isoflavones, Equol and Cardiovascular Disease: Pharmacological and Therapeutic Insights
Current Medicinal Chemistry Mechanism and Anticancer Activity of the Metabolites of an Endophytic Fungi from Eucommia ulmoides Oliv
Anti-Cancer Agents in Medicinal Chemistry Modulation of Microglial Innate Immunity in Alzheimers Disease by Activation of Peroxisome Proliferator-activated Receptor Gamma
Current Medicinal Chemistry Oxidative Stress and Cancer
Current Pharmaceutical Design Prospective Approaches of Herbal Novel Delivery System with Special Reference to the Herbal Nanosciences
Current Drug Therapy Recent Advances in the Membrane Receptor Initiated Vitamin D Signaling of Calcium and Phosphate Transport Across Intestinal and Kidney Epithelia
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)





